UnknownPhase 2NCT03768375
Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Studying Carcinoma of gallbladder and extrahepatic biliary tract
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Principal Investigator
- yingbin liu, PHD, M.D., Ph.DXinhua Hospital, Shanghai Jiao Tong University School of Medicine
- Intervention
- conventional chemotherapy(FORFIRINOX) combined with target agents(biological)
- Enrollment
- 150 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2016 – 2021
Study locations (1)
- Xinhua Hospital, Shanghai, Shanghai Municipality, China
Collaborators
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Ruijin Hospital · RenJi Hospital · Eastern Hepatobiliary Surgery Hospital · Huashan Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03768375 on ClinicalTrials.govOther trials for Carcinoma of gallbladder and extrahepatic biliary tract
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE2NCT06901622Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic CholangiocarcinomaThe First Affiliated Hospital of Zhengzhou University
- RECRUITINGNCT07337850Prospective Evaluation of 68Ga-FAPI PET in Biliary CancersTata Memorial Centre
- RECRUITINGPHASE2NCT06440993Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic CholangiocarcinomaInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- ACTIVE NOT RECRUITINGPHASE2NCT05712356A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid TumorsLisata Therapeutics, Inc.
- ENROLLING BY INVITATIONPHASE3NCT06671418Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary ObstructionErasmus Medical Center
- RECRUITINGNCT05404347NGS in Gallbladder Cancer and Response to TreatmentBanaras Hindu University
See all trials for Carcinoma of gallbladder and extrahepatic biliary tract →